A medical life science innovation company

Based at Karolinska Institute Science Park, Stockholm Sweden

Spotlights

Euroclear&Avanza

AUXESIS PHARMA HOLDING AB (publ) is now a settlement company and started with Euroclear as the securities institution and Avanza Bank as the company’s Issuance…

Production Site

Östersund AUXESIS PHARMA HOLDING AB (publ) is in the establishment phase of pharmaceutical manufacturing in Östersund, Sweden.  In September 2023 the company will submit an…

Protocol AGM 2023

Protocol from The AUXESIS PHARMA HOLDING AB (publ) Annual General Meeting 2023 is now available for download in the Investor Hub.
View all

Spotlights

Euroclear&Avanza

AUXESIS PHARMA HOLDING AB (publ) is now a settlement company and started with Euroclear as the securities institution and Avanza Bank as the company’s Issuance…

Production Site

Östersund AUXESIS PHARMA HOLDING AB (publ) is in the establishment phase of pharmaceutical manufacturing in Östersund, Sweden.  In September 2023 the company will submit an…

Protocol AGM 2023

Protocol from The AUXESIS PHARMA HOLDING AB (publ) Annual General Meeting 2023 is now available for download in the Investor Hub.
View all

Our Team

A team of medical experts

AUXESIS PHARMA HOLDING AB (publ), is a pharmaceutical company, based in Stockholm, Sweden. The team is interdisciplinary in the medical industry including a Certified Drug Consultant, Professor of Pharmacotherapy, Clinical Pharmacology and Sales and Marketing expertise. Auxesis Pharma Holding AB is a company that owns the rights of any additional and necessary patents in a specific medical research area.

Our product line

Key features

Our product line are designed for the global market. The company is working with the FDA for a second introduction to the US market, and are negotiating with strategic pharmaceutical companies for manufacturing and distribution. The active substances of our products has already been approved by the Medical Products Agency in Sweden, which will simplify the process for approval both domestically and globally.

Active ingredients

Are topical Painkillers Safe?

Animal dermatitis

Dermatitis and Dermatologic Problems in Dogs

Itchy insect bites

Do Topical Anti-Inflammatory Painkillers Really Work?

Product in focus

ASA.P®

ASA.P® is a non-prescription topical pain elimination drug that can be applied to the skin in different forms. The global challenge today is quick pain relief for topical exposure and infections from sun burn, wasp/ mosquito bites, herpes, nettle, jelly fish etc. Our research reveals that it drastically deminishes pain caused by insect bites, poison plants, rashes, eczema, herpes etc in its own, unique way.

Investor Hub

Financial information

News and updates from Auxesis Pharma for the Investor Hub exclusively. Documentation available for download.

Partners

Successfully partnering with external organizations that share our purpose

info@auxesis.se

+46 (0)8-771 43 00

  • Karolinska Institute Science Park
  • Fogdevreten 2A
  • 171 65 Solna Sweden
  • P.O.Box 3626
  • Regeringsgatan 63
  • 103 59 Stockholm

Copyright All rights reserved AUXESIS PHARMA HOLDING AB (publ) 2023